Skip to main content
OpenTrials

Clinical trial condition

Parathyroid Diseases

Explore clinical trials studying Parathyroid Diseases. Study availability and eligibility vary by location and protocol.

40 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Parathyroid Diseases trial results

Recruiting

A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism

NCT07081997

Conditions
Endocrine System Diseases, Hypoparathyroidism, Parathyroid Diseases
Locations
  • Ascendis Pharma Investigational Site Reno, Nevada, United States
  • Ascendis Pharma Investigational Site New York, United States
  • Ascendis Pharma Investigational Site Spokane Valley, Washington, United States
View Trial Details
Completed

A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH Administered Daily in Adults With Hypoparathyroidism

NCT04701203

Conditions
Endocrine System Diseases, Hypoparathyroidism, Parathyroid Diseases
Locations
  • Ascendis Pharma Investigational Site San Francisco, California, United States
  • Ascendis Pharma Investigational Site Chicago, Illinois, United States
  • Ascendis Pharma Investigational Site Rochester, Minnesota, United States
  • Ascendis Pharma Investigational Site Reno, Nevada, United States
View all 21 locations
View Trial Details
Completed

A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism

NCT04009291

Conditions
Endocrine System Diseases, Hypoparathyroidism, Parathyroid Diseases
Locations
  • Ascendis Pharma Investigational Site Chicago, Illinois, United States
  • Ascendis Pharma Investigational Site Rochester, Minnesota, United States
  • Ascendis Pharma Investigational Site Great Neck, New York, United States
  • Ascendis Pharma Investigational Site New York, United States
View all 15 locations
View Trial Details

Related conditions